Legislators
Bills
Statements
Lobbying
Travel
- Bills
- H.R.3991
H.R.3991: Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act of 2019
About This Bill
- Introduced July 25, 2019
- Latest Major Action Nov. 21, 2019
- See the one similar bills introduced in other congresses.
Bill Sponsor
Bill Cosponsor
Bill Version
- Introduced in House - July 25, 2019
Bill Summary
Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act of 2019 This bill limits in certain instances the number of patents that the manufacturer of a biologic drug can assert in a lawsuit against a company seeking to sell a biosimilar version of that drug. (A biologic drug is produced through natural processes or isolated from natural sources. A biosimilar version is substantially similar to the original biologic,...
(Source: Library of Congress)
What Lawmakers Are Saying About This Bill
Bill Actions
Date | Description |
---|---|
Nov. 21, 2019 |
Ordered to be Reported (Amended).
|
Nov. 21, 2019 |
Committee Consideration and Mark-up Session Held.
|
Nov. 19, 2019 |
Subcommittee on Courts, Intellectual Property, and the Internet Discharged.
|
Aug. 28, 2019 |
Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.
|
July 25, 2019 |
Referred to the House Committee on the Judiciary.
|
July 25, 2019 |
Introduced in the House by Hank Johnson (D-Ga.) |